vs
Side-by-side financial comparison of HAEMONETICS CORP (HAE) and RENAISSANCERE HOLDINGS LTD (RNR). Click either name above to swap in a different company.
RENAISSANCERE HOLDINGS LTD is the larger business by last-quarter revenue ($2.2B vs $1.3B, roughly 1.6× HAEMONETICS CORP). RENAISSANCERE HOLDINGS LTD runs the higher net margin — 23.5% vs 7.3%, a 16.2% gap on every dollar of revenue. On growth, HAEMONETICS CORP posted the faster year-over-year revenue change (4.8% vs -36.8%). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs -11.9%).
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
RenaissanceRe Holdings Ltd is a Bermudian provider of reinsurance, insurance and other related business services. The company operates in reinsurance, insurance and ventures.
HAE vs RNR — Head-to-Head
Income Statement — Q4 FY2026 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $1.3B | $2.2B |
| Net Profit | $97.3M | $515.8M |
| Gross Margin | 14.9% | — |
| Operating Margin | 83.4% | — |
| Net Margin | 7.3% | 23.5% |
| Revenue YoY | 4.8% | -36.8% |
| Net Profit YoY | -42.0% | 72.6% |
| EPS (diluted) | — | $6.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $2.2B | ||
| Q4 25 | $339.0M | $3.0B | ||
| Q3 25 | $327.3M | $3.2B | ||
| Q2 25 | $321.4M | $3.2B | ||
| Q1 25 | $330.6M | $3.5B | ||
| Q4 24 | $348.5M | $2.3B | ||
| Q3 24 | $345.5M | $4.0B | ||
| Q2 24 | $336.2M | $2.8B |
| Q1 26 | $97.3M | $515.8M | ||
| Q4 25 | $44.7M | $760.5M | ||
| Q3 25 | $38.7M | $916.5M | ||
| Q2 25 | $34.0M | $835.4M | ||
| Q1 25 | $58.0M | $170.0M | ||
| Q4 24 | $37.5M | $-189.7M | ||
| Q3 24 | $33.8M | $1.2B | ||
| Q2 24 | $38.4M | $503.9M |
| Q1 26 | 14.9% | — | ||
| Q4 25 | 59.7% | — | ||
| Q3 25 | 59.5% | — | ||
| Q2 25 | 59.8% | — | ||
| Q1 25 | 58.4% | — | ||
| Q4 24 | 55.5% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 52.0% | — |
| Q1 26 | 83.4% | — | ||
| Q4 25 | 19.9% | 42.5% | ||
| Q3 25 | 17.9% | 46.3% | ||
| Q2 25 | 16.8% | 41.8% | ||
| Q1 25 | 21.6% | -2.0% | ||
| Q4 24 | 16.9% | -3.6% | ||
| Q3 24 | 15.0% | 43.7% | ||
| Q2 24 | 11.8% | 25.0% |
| Q1 26 | 7.3% | 23.5% | ||
| Q4 25 | 13.2% | 25.6% | ||
| Q3 25 | 11.8% | 28.7% | ||
| Q2 25 | 10.6% | 26.1% | ||
| Q1 25 | 17.5% | 4.9% | ||
| Q4 24 | 10.8% | -8.3% | ||
| Q3 24 | 9.8% | 29.8% | ||
| Q2 24 | 11.4% | 17.8% |
| Q1 26 | — | $6.57 | ||
| Q4 25 | $0.95 | $16.16 | ||
| Q3 25 | $0.81 | $19.40 | ||
| Q2 25 | $0.70 | $17.20 | ||
| Q1 25 | $1.17 | $3.27 | ||
| Q4 24 | $0.74 | $-3.76 | ||
| Q3 24 | $0.66 | $22.62 | ||
| Q2 24 | $0.74 | $9.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.4M | $1.6B |
| Total DebtLower is stronger | $1.2B | — |
| Stockholders' EquityBook value | $796.3M | $4.3B |
| Total Assets | $2.4B | $53.7B |
| Debt / EquityLower = less leverage | 1.53× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.4M | $1.6B | ||
| Q4 25 | $363.4M | $1.7B | ||
| Q3 25 | $296.4M | $1.7B | ||
| Q2 25 | $292.9M | $1.4B | ||
| Q1 25 | $306.8M | $1.6B | ||
| Q4 24 | $320.8M | $1.7B | ||
| Q3 24 | $299.3M | $1.6B | ||
| Q2 24 | $344.4M | $1.6B |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $2.3B | ||
| Q3 25 | $1.2B | $2.2B | ||
| Q2 25 | $1.2B | $2.3B | ||
| Q1 25 | $1.2B | $2.8B | ||
| Q4 24 | — | $1.9B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | — | $2.0B |
| Q1 26 | $796.3M | $4.3B | ||
| Q4 25 | $911.5M | $11.6B | ||
| Q3 25 | $849.2M | $11.5B | ||
| Q2 25 | $882.3M | $10.8B | ||
| Q1 25 | $820.8M | $10.3B | ||
| Q4 24 | $906.9M | $10.6B | ||
| Q3 24 | $878.9M | $11.2B | ||
| Q2 24 | $905.4M | $10.2B |
| Q1 26 | $2.4B | $53.7B | ||
| Q4 25 | $2.5B | $53.8B | ||
| Q3 25 | $2.4B | $54.5B | ||
| Q2 25 | $2.5B | $54.7B | ||
| Q1 25 | $2.5B | $53.6B | ||
| Q4 24 | $2.5B | $50.7B | ||
| Q3 24 | $2.5B | $52.8B | ||
| Q2 24 | $2.5B | $51.6B |
| Q1 26 | 1.53× | — | ||
| Q4 25 | 1.34× | 0.20× | ||
| Q3 25 | 1.44× | 0.19× | ||
| Q2 25 | 1.39× | 0.21× | ||
| Q1 25 | 1.49× | 0.27× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.17× | ||
| Q2 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $293.2M | — |
| Free Cash FlowOCF − Capex | $209.9M | — |
| FCF MarginFCF / Revenue | 15.7% | — |
| Capex IntensityCapex / Revenue | 2.5% | — |
| Cash ConversionOCF / Net Profit | 3.01× | — |
| TTM Free Cash FlowTrailing 4 quarters | $417.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $293.2M | — | ||
| Q4 25 | $93.6M | $483.0M | ||
| Q3 25 | $111.3M | $1.6B | ||
| Q2 25 | $17.4M | $1.5B | ||
| Q1 25 | $116.6M | $157.8M | ||
| Q4 24 | $43.8M | $778.9M | ||
| Q3 24 | $48.8M | $1.5B | ||
| Q2 24 | $-27.4M | $1.2B |
| Q1 26 | $209.9M | — | ||
| Q4 25 | $87.2M | — | ||
| Q3 25 | $106.3M | — | ||
| Q2 25 | $13.6M | — | ||
| Q1 25 | $100.9M | — | ||
| Q4 24 | $35.2M | — | ||
| Q3 24 | $39.4M | — | ||
| Q2 24 | $-33.1M | — |
| Q1 26 | 15.7% | — | ||
| Q4 25 | 25.7% | — | ||
| Q3 25 | 32.5% | — | ||
| Q2 25 | 4.2% | — | ||
| Q1 25 | 30.5% | — | ||
| Q4 24 | 10.1% | — | ||
| Q3 24 | 11.4% | — | ||
| Q2 24 | -9.8% | — |
| Q1 26 | 2.5% | — | ||
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 1.7% | — |
| Q1 26 | 3.01× | — | ||
| Q4 25 | 2.09× | 0.64× | ||
| Q3 25 | 2.88× | 1.73× | ||
| Q2 25 | 0.51× | 1.76× | ||
| Q1 25 | 2.01× | 0.93× | ||
| Q4 24 | 1.17× | — | ||
| Q3 24 | 1.44× | 1.26× | ||
| Q2 24 | -0.71× | 2.41× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.